Cargando…
Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity—a computed tomography study
BACKGROUND: Around 25% of the world population was affected by the metabolic-related fatty liver disorder. Hepatic steatosis is frequently observed in conjunction with hypertension, obesity comorbidities, and diabetes. We evaluate the hepatic steatosis frequency found in chest CT exams of COVID-19-p...
Autores principales: | Ali, Asmaa, Hasan, Mona, Hamed, Shaimaa, Elhamy, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274961/ https://www.ncbi.nlm.nih.gov/pubmed/34777870 http://dx.doi.org/10.1186/s43066-021-00131-6 |
Ejemplares similares
-
Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016) -
The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings
por: Parlak, Selçuk, et al.
Publicado: (2021) -
Hepatic steatosis as an independent risk factor for severe disease in patients with COVID‐19: A computed tomography study
por: Palomar‐Lever, Andres, et al.
Publicado: (2020) -
Moderate to severe hepatic steatosis on computerized tomography imaging: Prevalence in obese Pacific Islanders and Asians
por: Thomas, Bradley James Ikaika, et al.
Publicado: (2023) -
Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
por: Torgersen, Jessie, et al.
Publicado: (2019)